Find Academic Supervisors

• Immunology
• Rheumatology
• Applied Immunology
• +8 more

Dr. Andrew Craig is an Associate Professor in the Department of Biomedical and Molecular Sciences at Queen's University, affiliated with the Faculty of Health Sciences and the Queen’s Cancer Research Institute. He holds cross appointments in the Cancer Biology & Genetics division and the Translational Institute of Medicine (TIME). He earned his PhD in Biochemistry from McGill University (1998) and completed postdoctoral training at Queen's University before joining the faculty in 2002. His research focuses on molecular mechanisms of cancer progression, immune suppression, and metastasis, with a particular emphasis on tumor suppressor miRNAs, actin-driven metastasis, and immunotherapy strategies. Education: PhD in Biochemistry, McGill University (1998) BSc in Biochemistry, Queen's University (1993) Research Interests: Dr. Craig’s work spans immunology, oncology, and cellular biology. Key areas include: Inflammatory mechanisms and inflammasomes Cancer immunotherapy and metastasis TGF-β signaling pathways MicroRNA biomarkers in lung cancer Actin-targeting compounds for cancer treatment Research Highlights: His lab has developed novel synthetic antibodies targeting TGF-β to improve chemotherapy efficacy in ovarian cancer models. Recent studies focus on functional genomic screening to identify vulnerabilities in inflammatory breast cancer and defining miRNA biomarkers in immunotherapy-treated patients. His work integrates advanced techniques like confocal microscopy and flow cytometry. Awards: Canadian Cancer Society Young Investigator Award (2011) Grants & Funding: Dr. Craig maintains continuous external funding for his research, supported by grants from agencies such as the Canadian Cancer Society and the Canadian Institutes of Health Research (CIHR). Labs & Affiliations: He leads the Craig Lab within the Department of Biomedical and Molecular Sciences and collaborates with the Queen’s Cancer Research Institute and Translational Institute of Medicine (TIME). His research bridges basic science and clinical translation, emphasizing preclinical models of disease and precision medicine approaches.

Eva KaufmannView profile

Assistant Professor

• Trained Immunity
• Immunology
• Infectious Diseases
• +7 more

Dr. Eva Kaufmann is an Assistant Professor in the Department of Biomedical and Molecular Sciences at Queen's University, cross-appointed to the Translational Institute of Medicine (TIME). Her research focuses on trained immunity mechanisms in infection, vaccination, and asthma, with additional interests in public health and hospital infection control. Education: DVM (2006-2012), Justus-Liebig-University Giessen, Germany PhD in Immunology (2012-2016), Paul Ehrlich Institute & Justus-Liebig-University Giessen Postdoctoral Fellowship (2016-2022), McGill University Research Interests: Trained immunity in infection and vaccination Host-pathogen interactions in tuberculosis BCG vaccination cross-protection Immune tolerance mechanisms Inflammatory responses in chronic diseases Public health systems improvement Key Research Trends: Her work bridges basic immunology with clinical applications, emphasizing how innate immune training shapes resistance to pathogens like Mycobacterium tuberculosis and influenza. Recent studies highlight vaccination-induced protective memory and metabolic pathways governing disease tolerance. Work on SARS-CoV-2 revealed limitations of BCG cross-protection but identified obesity's role in impaired antiviral defense. Lab Team: Supervises six researchers including Gabriella Stefan, Vidthiya Jeyanathan, and Conrad Pietrzak. Collaborates on Duchenne muscular dystrophy immunology and diaphragm macrophage dynamics.

Philip OsdobyView profile

Professor

• Bone Biology
• Cellular Immunology
• Regenerative Medicine
• +3 more

Philip Osdoby is a Professor in the Department of Biology at Washington University. His research focuses on bone development, pathological bone loss, and regenerative medicine, particularly cell-based therapies and tissue engineering. He investigates cell-molecular interactions involving osteoclasts, osteoblasts, immune cells, and vascular cells, emphasizing endocrine and local signaling pathways. His work spans bone biology, cellular immunology, and molecular mechanisms underlying skeletal disorders. Key areas include osteoclastogenesis regulation, cytokine signaling (e.g., IL-1, TNF-α), chemokine receptor (CXCR4) roles in osteoclast recruitment, and biomineralization processes. He explores autocrine feedback mechanisms (e.g., iNOS/NO pathways) and the interplay between angiogenesis and bone resorption in vivo models like the chick chorioallantoic membrane. Publications highlight osteoclast formation from RAW 264.7 cells, galectin-3 isoforms, and SDF-1-driven osteoclast migration. His studies often integrate in vitro and in vivo approaches to dissect bone cell microenvironment dynamics. Philip Osdoby holds no explicitly listed scientific awards. His lab’s research has contributed to understanding osteoporosis, inflammatory bone diseases, and regenerative strategies for bone repair.

• Malaria Research
• Parasitology
• Vaccine Development
• +3 more

Mary Galinski is a Professor in the Hubert Department of Global Health at Emory University's School of Medicine. Her research focuses on malaria pathogenesis, vaccine development, and host-parasite interactions using non-human primate models. She has contributed extensively to understanding Plasmodium species biology, particularly Plasmodium vivax and Plasmodium knowlesi, through proteomics, transcriptomics, and systems biology approaches. Her work emphasizes antigenic variation mechanisms, immune response dynamics, and the application of genomic technologies to study malaria lifecycle stages. Notable contributions include defining SICAvar protein roles in cytoadhesion and identifying biomarkers for vaccine development. She collaborates on projects involving drug repurposing and systems biology frameworks to address malaria complexity. Galinski's research integrates metabolomics, transcriptomics, and proteomics data to uncover host-pathogen relationships. Her lab employs cutting-edge methods like single-molecule genome sequencing and Bayesian network modeling to dissect malaria infection dynamics. Recent studies explore microbiome disruptions during malaria and the immunological basis of clinical tolerance in infections. Her publications highlight translational research bridging basic science and public health, with a focus on vivax malaria's unique challenges such as relapsing infections and hypnozoite dormancy. She advocates for non-human primate models as critical tools for studying malaria's systemic effects and vaccine efficacy.

• Food Science
• Protein Chemistry
• Immunology
• +3 more

Prof. Harry Wichers is a Professor at Wageningen University & Research, specializing in Food Quality and Design. His work focuses on protein chemistry, immunology, and food allergy mechanisms. He leads projects exploring how food processing affects protein digestibility and immunogenicity, with a particular emphasis on infant nutrition and dairy/plant protein substitutes. Research interests include the Maillard reaction's impact on protein properties, allergen formation, and macrophage activation pathways. His studies often involve in vitro digestion models and collaborations with industry. Key contributions include evaluating plant-based infant formula alternatives and understanding heated milk proteins' tolerance in allergic children. Over 296 publications and 25 active projects highlight his extensive research portfolio. Supervised 20+ PhD candidates, including work on goat milk proteins, soy glycated peptides, and AGEs in neurodegeneration. Media engagements emphasize China-Dutch agricultural cooperation and food allergy trends.

Mark RossView profile

Associate Professor

• Immunology
• Exercise Physiology
• Ageing
• +6 more

Mark Ross is an Associate Professor at Heriot-Watt University, affiliated with the School of Energy, Geoscience, Infrastructure and Society and the Institute for Life and Earth Sciences. He holds roles as Director of Research for the Sport and Exercise Science department and Programme Director for the BSc (Hons) Sport and Exercise Science. He chairs the EGIS Research Ethics Committee and previously served as Programme Leader at Edinburgh Napier University. Education includes a 1st Class Honours Degree in Sport and Exercise Science from Heriot-Watt University (2009, awarded James Watt Medal), an MRes in Exercise Physiology from Waterford Institute of Technology (2011), and a PhD in Exercise Physiology from Edinburgh Napier University (focused on endothelial progenitor cells). His research explores immune cell contributions to inflammation and tissue repair, leveraging exercise as a modulator. Techniques include flow cytometry to study immune cell activation in human samples from exercise studies. Key interests span T-cells, macrophages, aging, and exercise-induced immunological changes. Recent articles highlight work on ultra-endurance exercise's effects on T-cells, vascular aging in centenarians, and exercise-induced progenitor cell mobilization. His studies often integrate clinical, immunological, and physiological perspectives. Awards: James Watt Medal (2009) PhD projects include exercise's role in T-cell-mediated inflammation, immune health in athletes, and exercise in inflammatory conditions. He actively seeks research grants and collaborates on global projects like VascAgeNet. His work contributes to UN SDGs related to health and longevity. Labs/Teams: Active within the Institute for Life and Earth Sciences, collaborating on vascular aging, exercise immunology, and cardiometabolic disease research.

• Animal Science
• Nutrition
• Biotechnology
• +9 more

Konstantinos Mountzouris is a Professor at the Department of Animal Science, Agricultural University of Athens (AUA). He holds a PhD in Food and Agricultural Biotechnology from the University of Reading, UK, and has extensive experience in postdoctoral research and academic roles including Lecturer, Assistant Professor, and Associate Professor at AUA and Harokopio University. His primary affiliation is with AUA's Laboratory of Nutritional Physiology & Feeding, where he focuses on research and teaching. Education: Bachelor's Degree in Agriculture, Department of Animal Science, AUA (1994) Postgraduate Diploma in Food and Agricultural Biotechnology, University of Reading, UK (1995) PhD in Food and Agricultural Biotechnology, University of Reading, UK (1999) Research interests center on animal and human nutrition, particularly the effects of bioactive components (probiotics, prebiotics, phytogenics) on gut health, microbiota composition, and physiological functions. He investigates alternatives to antibiotic growth promoters, enzyme technology, and dietary strategies to enhance antioxidant capacity and intestinal barrier function. His work often involves nutrigenomic approaches to study gene expression related to immune responses, oxidative stress, and nutrient absorption. Recent articles highlight trends in phytogenic feed additives, gut microbiota modulation, mycotoxin mitigation, and sustainable utilization of by-products in feed formulation. These studies emphasize natural solutions for improving animal productivity while reducing environmental impact. Scientific awards section remains empty as no honors or fellowships were explicitly mentioned in the provided texts. Mountzouris has collaborated extensively with researchers like Paraskeuas V and Fegeros K on projects funded by institutions such as the EU's antibiotic growth promoter alternatives initiative. His research extends to multidisciplinary areas including human dietary patterns (e.g., Mediterranean diet studies) and insect husbandry (e.g., Hermetia illucens bioconversion). Labs and teams: He is associated with the Laboratory of Nutritional Physiology & Feeding at AUA, contributing to its research activities, infrastructures, and extension services. His work often involves collaborations across multiple departments and international partners, reflecting his role in bridging academic research with practical applications in animal production and food safety.

• Neuroscience
• Microbiome Analysis
• Environmental Health
• +3 more

Yu Sun is an Associate Research Scientist in Neuroscience at Yale School of Medicine (Yale University). Their research focuses on interdisciplinary areas including neurodegenerative biomarkers, microbiome-metabolome interactions, environmental health impacts, and neuroinflammation mechanisms. Sun has contributed to high-impact studies such as the Aging Biomarker Consortium framework for auditory system aging and novel PET tracer development for oxidative stress imaging. Their work bridges molecular biology, biomedical engineering, and computational methods to address complex health challenges. Research highlights include investigating microglial regulation of cerebrovascular reactivity and environmental determinants of childhood rhinitis. Sun has published extensively in prestigious journals like Nature Biomedical Engineering and Cell Research, with a strong emphasis on translational neuroscience and systems biology approaches.

• Pulmonary Hypertension
• Clinical Biomarkers
• Combination Therapy
• +3 more

Terence Trow, M.D., is an Associate Clinical Professor of Medicine and Director of the Pulmonary Vascular Disease Program at Yale School of Medicine. His expertise lies in pulmonary hypertension, particularly clinical biomarkers and combination therapies. He holds academic appointments in the Department of Pulmonary, Critical Care & Sleep Medicine and contributes to the Winchester Center for Lung Disease and Lysosomal Disease & Inherited Metabolic Liver Disease Program. Dr. Trow graduated summa cum laude from Bowdoin College (Biochemistry, 1982) and earned his MD from Dartmouth Medical School (1986). He trained in Internal Medicine at New York Hospital-Cornell University Medical College and completed Pulmonary/Critical Care Fellowship at Yale. His research focuses on advancing diagnostic criteria and therapeutic strategies for pulmonary arterial hypertension. He has authored over 40 peer-reviewed articles, including seminal work on biomarkers and guideline-driven therapies. His editorial roles include Deputy Editor of Proceedings of the American Thoracic Society and contributions to Clinical Pulmonary Medicine . Dr. Trow has received multiple accolades, including Fellowships from the American College of Physicians and American College of Chest Physicians. He has been named Attending of the Year at two major hospitals and actively participates in national organizations like the Pulmonary Hypertension Association. His clinical practice emphasizes multidisciplinary care for complex pulmonary vascular diseases. He collaborates with teams at the Yale Pulmonary Hypertension Center and has pioneered programs at Yale and Stony Brook.

• Neurosurgery
• Neuro-Oncology
• Genomics
• +4 more

Hasan Alanya is a Researcher in the Department of Neurosurgery at Yale School of Medicine. His work focuses on genomic characterization of brain tumors, including meningiomas, pituitary adenomas, and other neurological disorders. He specializes in molecular pathology, somatic mutations, and the genetic basis of tumor behavior. His research bridges clinical neurosurgery with advanced genomic techniques to understand tumor progression and racial/ethnic variations in disease outcomes. Key research interests include neuro-oncology, somatic mutation analysis, and translational applications of genomic data. His studies investigate how genetic mutations drive tumor development and response to therapy, particularly in pituitary and spinal tumors. Recent work emphasizes the role of thrombocytes in immune responses and the utility of single-cell data for refining bulk genomic analyses. Publications highlight interdisciplinary approaches, combining genomics with clinical observations to address gaps in understanding tumor heterogeneity and treatment strategies. Collaborations span neurosurgery, oncology, and computational biology to advance personalized medicine in neuro-oncology.

Juan S. GneccoView profile

Assistant Professor

• Tissue Engineering
• Reproductive Biology
• Endometriosis Research
• +5 more

Dr. Juan S. Gnecco serves as Assistant Professor in the Department of Biomedical Engineering at Tufts University School of Engineering, holding concurrent appointments as Graduate Biomedical Sciences Member in Genetics, Molecular and Cellular Biology and Associate Principal Investigator at Tufts Medical Center's Mother Infant Research Institute. His laboratory bridges tissue engineering and reproductive biology to address women's health inequities through innovative engineering approaches. Dr. Gnecco's research focuses on three interconnected domains: Tissue engineering and organoid systems for modeling the human endometrium using synthetic hydrogels that replace Matrigel, enabling fully defined studies of hormone-mediated processes Tissue clearing and 3D pathology techniques to visualize endometriotic lesion architecture in unprecedented detail Disease modeling of endometriosis as an estrogen-dependent, progesterone-resistant condition affecting over 10% of women, characterized by debilitating pelvic pain and infertility His work has established critical tools for deciphering immune-endocrine mechanisms in reproductive physiology and disease pathogenesis. Dr. Gnecco's publication record demonstrates consistent advancement in modeling the female reproductive tract, with recent work emphasizing biophysical microenvironment effects on endometrial cell behavior, synthetic matrix development for organoid culture, and molecular characterization of endometriosis. His research trajectory shows deepening focus on translational applications of engineering approaches to endometriosis pathology. Recognition includes: Multiple Gates Foundation funding rounds (2018-present) for phenotypic screening models of the female reproductive tract Rising Star in Engineering and Health by Columbia University (2020) Invited presentations at Society for Reproductive Investigation and Gates Foundation Consortium Editorial board membership for Frontiers in Reproductive Health As Principal Investigator of the Laboratory of Reproductive Engineering, Dr. Gnecco leads interdisciplinary efforts to identify novel therapeutic targets for endometriotic diseases through physiomimetic model systems. His educational background includes a PhD in Cellular and Molecular Pathology from Vanderbilt University Medical Center (2018) and BS in Biotechnology from Rutgers University.

Ferdinandy PéterView profile

Professor

• Molecular mechanisms of cardioprotection
• Translational cardiovascular sciences
• Cardiovascular pharmacology
• +3 more

Péter Ferdinandy is a Professor of Pharmacology and former Vice Rector for Science & Innovations at Semmelweis University, Budapest. He concurrently holds a part-time professorship in Biochemistry at the University of Szeged. His roles include leading the Department of Pharmacology and Pharmacotherapy at Semmelweis and directing the Cardiovascular Research Group at Szeged. He is also the founder and CEO of Pharmahungary Group, a biotech company focused on R&D. Dr. Ferdinandy’s research focuses on molecular mechanisms of cardioprotection in comorbidities, translational cardiovascular sciences, and drug cardiotoxicity. His work bridges basic science and clinical applications, with emphasis on ischemia/reperfusion injury, diabetic cardiomyopathy, and immune checkpoint inhibitor-induced cardiotoxicity. Key achievements include being listed as a Highly Cited Researcher (2014–2024) and receiving the 1999 Young Investigator Award. He has held leadership roles in international societies, including chairing the ESC Working Group on Cellular Biology of the Heart and serving as president of the ISHR European Section. His educational background includes medical training, a PhD, and an MBA. He has contributed to over 200 publications, focusing on cardioprotective microRNAs (protectomiRs), drug development, and cardiovascular pharmacotherapy strategies. Current research explores therapeutic targets for heart failure and biomarkers for drug-induced cardiotoxicity.

Victoria GossView profile

Researcher

• Respiratory Medicine
• Lipidomics
• Translational Medicine
• +3 more

Dr. Victoria Goss PhD serves as Head of the Early Diagnosis and Translational Group at the University of Southampton, focusing on respiratory and metabolic research with clinical applications. Her work bridges laboratory science and patient care through translational approaches to respiratory disorders. Her research centers on lipid metabolism in respiratory diseases , particularly examining surfactant phospholipid kinetics in ventilated children, cellular phosphatidylcholine dynamics in ARDS, and lipidomic profiling in asthma. Key interests include pediatric pulmonology , asthma stratification , and early diagnostic biomarkers for conditions like pancreatic cancer. Her methodology integrates advanced lipidomics with clinical observational studies to identify treatable traits in chronic respiratory diseases. Analysis of her 10 most recent publications (2018-2024) reveals consistent focus on lipid-based mechanisms across respiratory conditions, with increasing emphasis on translational applications including diagnostic protocols (MecROX, DEPEND studies) and asthma endotyping. Her work frequently employs mass spectrometry lipid profiling and cellular kinetics analysis in both pediatric and adult populations. Current research initiatives include the MecROX study on oxidative stress in ventilated patients and DEPEND study for pancreatic cancer screening. She actively collaborates with European consortia like U-BIOPRED, reflecting her integration within international respiratory research networks.

Ulrich EiselView profile

Professor

• Neuroimmunology
• Alzheimer's Disease
• Neurodegenerative Disorders
• +3 more

Ulrich Eisel is a Professor at the University of Groningen, Faculty of Science and Engineering, leading the Eisel Lab focused on Molecular Neurobiology and Neuroimmunology. His research investigates the role of TNF receptors in neurodegenerative diseases like Alzheimer’s and Parkinson’s, emphasizing translational therapies. He holds roles as course coordinator for Neuroscience Research and Molecular and Cellular Neuroscience, and lectures on Neurobiology and Aging. Education: PhD from Justus-Liebig-University Giessen and Tübingen (Germany), postdoctoral training at the NIH. His work integrates behavioral biology with neuroimmunology, exploring inflammatory pathways in disease progression. He serves on scientific advisory boards for BRAINS and Alzheimer Nederland, and chairs the BCN program committee. Research highlights include TNFR2 agonist therapies for Alzheimer’s and remyelination studies in MS models. Collaborations span global institutions, focusing on immune-neural interactions and drug development. Advising: Supervised 14 students and leads projects like 'Peripheral targeting of TNFR1' and 'ARTOS clinical development.' His lab aims to bridge basic science with clinical applications, addressing aging-related neurological disorders.

• HIV/AIDS Research
• Virology
• Immunology
• +3 more

Andrew J. Henderson is a Professor at the Boston University Chobanian & Avedisian School of Medicine, holding roles as Assistant Dean of Graduate Medical Sciences and Co-Director of the BU PREP post-bac program. His primary research focuses on cellular mechanisms regulating HIV replication and transcription, with emphasis on T cell signaling, latency, and inflammatory processes. He earned his B.S., M.S., and Ph.D. in Microbiology from the University of California, Riverside. Research Interests: Dr. Henderson investigates how T cell signals and transcriptional machinery control HIV expression, particularly mechanisms underlying latency and viral persistence. His lab explores pathways involving CD28 costimulation, RNA polymerase II elongation, and chromatin modifications. These studies provide insights into broader topics like signal transduction, immune dysfunction, and inflammatory disorders. Key Contributions: His work includes identifying transcriptional checkpoints (e.g., NELF and Pcf11 factors), characterizing opioid use’s impact on HIV reservoirs, and developing CRISPR-based tools for HIV repression. He has also contributed to training programs in Liberia and Uganda through initiatives like the BU-UL Partnership and Fogarty grants. Awards: Notable recognitions include the Boston SciCafe Award, NIH study section leadership, and postdoctoral fellowships from the Leukemia Society of America and Aaron Diamond Foundation. Grants & Labs: Active grants include NIH-funded investigations into HIV latency, opioid effects on reservoirs, and global health partnerships (e.g., BULEEVR in Liberia). His lab collaborates with institutions like the Providence/Boston CFAR and the BU CTSI.